ExaGrid to Present Its “Nutanix-Ready” Hyperconverged Secondary Storage for Backup at Nutanix .NEXT Europe 2018

LONDON-Tuesday 27 November 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- ExaGrid, a Nutanix Elevate Partner, announced today that it will participate as a Gold sponsor at Nutanix’s annual .NEXT Europe conference on November 27-29. At the event, ExaGrid will present its “Nutanix-Ready” hyperconverged backup storage solution that supports the leading backup applications used with AHV, including solutions from HYCU, Veeam, Commvault, Veritas, and others. At the event, Graham Woods, Vice President of International Systems Engineering at ExaGrid, will lead a session on next-generation enterprise cloud and backup storage, and ExaGrid will be hosting Booth G05 in the Golden Village at ExCeL.

Customers attending .NEXT will learn how they benefit from a true end-to-end, seamless storage environment when combining Nutanix, their supported backup application, and ExaGrid. Nutanix pioneered the hyperconverged infrastructure space, which combines compute, storage and networking into an all-in-one solution for flexible scaling. ExaGrid offers a complementary scale-out architecture, ensuring maximum uptime and lowering the cost of long-term backup retention.

“I believe that Nutanix is the most revolutionary enterprise cloud solution that we’ve seen in the last decade and as a result, we’ve seen an unprecedented response from IT organizations to embrace Nutanix,” said Bill Andrews, President and CEO at ExaGrid. “ExaGrid shares Nutanix’s technological vision as evidenced by our mirrored architectures and general approach to storage, whether on the front or back end.”

ExaGrid’s scale-out architecture consistently delivers fast backups in Nutanix environments due to its unique landing zone, and can quickly restore data and boot VMs by avoiding data rehydration. ExaGrid keeps the backup window fixed in length as data grows, and avoids costly and disruptive forklift upgrades in Nutanix IT data centers. Appliance models of varying capacities allow customers to buy what they need as they need it; older and newer appliances of any capacity can be used in the same scale-out system, eliminating product obsolescence and protecting the customer’s IT investment.

.NEXT Conference is the IT industry’s leading data center and cloud conference where executives, IT infrastructure and operations leaders, architects, devops practitioners and partners learn and discuss state-of-the-art practices on how to build and run enterprise clouds, on their terms, that provide agility and foster innovation to give businesses a competitive edge. This year’s Europe conference will be held on November 27-29 at ExCeL in London, UK.

About ExaGrid
ExaGrid provides hyper-converged secondary storage for backup with data deduplication, a unique landing zone, and scale-out architecture. ExaGrid’s landing zone provides for the fastest backups, restores, and instant VM recoveries. Its scale-out architecture includes full appliances in a scale-out system and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades. Visit us at www.exagrid.com or on LinkedIn. See what ExaGrid customers have to say about their own ExaGrid experiences and why they now spend significantly less time on backup.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181126005806/en/

Contacts

Christine Murphy
ExaGrid
cmurphy@exagrid.com
508-898-2872 x248

The French Ministry of Interior Selects Gemalto to Secure Critical Communication Mobile Networks

Providing security and connectivity solutions for Public Safety mobile networks used by National Police and Gendarmerie services across France and French territories worldwide
AMSTERDAM-Tuesday 27 November 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- The French Ministry of Interior has selected Gemalto, the world leader in digital security, to deliver robust connectivity and security in next-generation cellular networks used by officers from law enforcement and national security units for critical communication.

Today Public Safety networks are typically used where security forces and first responders require 100% reliable voice and simple data communication. These critical communication networks are migrating towards 4G/5G1 to benefit from high-speed data connectivity, which enables real-time video applications.

The French enforcement agencies will benefit from private mobile broadband coverage from existing public LTE networks and ad-hoc deployable tactical bubbles2, in different locations, with secure and dedicated access rights for their personnel. In only seconds, security force agents can intuitively switch between mobile networks, in response to operational requirements or unexpected coverage issues. Gemalto will provide its leading expertise by delivering customized SIMs, eSIMs and the related subscription management3 solutions.

“Gemalto’s unique blend of expertise across device security, authentication and secure connectivity allows us to deploy reliable, resilient and trusted private critical communication networks for French national security units” said General Bruno Poirier Coutansais, Head of information system technologies for national security at the French Ministry of Interior. “It will also help to comply with the most stringent regulations - e.g. IOPS4 - for ultra-secure mobile networks.”

“The global Public Safety LTE infrastructure market is expected to increase fourfold by the end of 2020 to reach over two billion USD5. Sophisticated cyber-threats pose a serious risk to these networks that military, police and other Public Safety agencies rely on,” Frédéric Vasnier, Executive Vice President, Mobile Services & IoT at Gemalto. “Our recognized expertise in authentication and protection allows us to answer the pressing need for pre-5G customizable connectivity, enhanced network data protection and device security in the field of critical, tactical and secure communications.”

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.

Our 15,000 employees operate out of 114 offices, 40 personalization and data centers, and 35 research and software development centers located in 47 countries.

For more information visit www.gemalto.com, or follow @gemalto on Twitter.

1 e.g. hybrid LTE-PMR (Private Mobile Radio) or full LTE networks
2 A tactical bubble is an autonomous, robust and secure private network that can be deployed in a few hours to ensure mobile coverage around a specific mission-critical field of operations such as terrorist attack, war or natural disaster. It is aimed for up to few hundred users from the emergency services and the military.
3 Gemalto On Demand Connectivity ensures secure remote management of embedded SIM (eSIM)-based mobile subscriptions. It is compliant with trade body GSMA’s Remote SIM Provisioning specifications. Gemalto Advanced OTA ensures secure remote management of the 4G and 5G SIM and eSIM file and application lifecycle.
4 IOPS stands for “Isolated E-UTRAN (Evolved Universal Terrestrial Radio Access Network) Operation for Public Safety”. IOPS is a 3GPP-endorsed specification for radio access networks used in mission critical network operation for Public Safety.
5 SNS Research: « The Public Safety LTE & Mobile Broadband Market: 2016 – 2030 – Opportunities, Challenges, Strategies & Forecasts »

View source version on businesswire.com: https://www.businesswire.com/news/home/20181126005089/en/

Contacts

Gemalto media contacts:
Tauri Cox
North America
+1 512 257 3916
tauri.cox@gemalto.com

Sophie Dombres
Europe Middle East & Africa
+33 4 42 36 57 38
sophie.dombres@gemalto.com

Piyush Prakash
Asia Pacific
+91 11 6623 1200
piyush.prakash@gemalto.com

Enriqueta Sedano
Latin America
+52 5521221422
enriqueta.sedano@gemalto.com

Permalink : https://www.aetoswire.com/news/the-french-ministry-of-interior-selects-gemalto-to-secure-critical-communication-mobile-networks/en

PTC Adds Artificial Intelligence and Generative Design Capabilities to Enhance and Expand its CAD Portfolio with Acquisition of Frustum

Cutting-Edge Technologies to Guide Engineers and Designers to the Next Generation of Products


NEEDHAM, Mass.-Tuesday 27 November 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- PTC (NASDAQ: PTC) today announced that it has acquired Frustum Inc., an advanced generative design software company, for approximately $70 million. Frustum’s technology for generative design—an approach that leverages artificial intelligence (AI) to generate design options—is a transformative addition to the PTC Creo portfolio.

Based in Boulder, Colorado, Frustum offers patented desktop and cloud-based engineering software that enables designers and engineers to go beyond the limits of their personal experience by leveraging powerful AI capabilities that guide the discovery of high-performance, next-generation product designs.

“PTC is pushing the boundaries of innovation with this acquisition,” said Jim Heppelmann, president and CEO, PTC. “Creo is core to PTC’s overall strategy, and the embedded capabilities from ANSYS and, later, Frustum will elevate Creo to a leading position in the world of design and simulation. With breakthrough new technologies such as AR/VR, high-performance computing, IoT, AI, and additive manufacturing entering the picture, the CAD industry is going through a renaissance period, and PTC is committed to leading the way.”

Frustum complements PTC’s strategic relationship with ANSYS, which was announced at LiveWorx in June 2018, and will bring analysis upstream to the very start of the design process. With embedded Frustum and ANSYS capabilities, Creo will be able to recommend design approaches using generative design, guide the user through the iterative design process using ANSYS Discovery Live, and ultimately validate the full product design at scale using the broader ANSYS Discovery suite. With these capabilities embedded in Creo, engineers will have unmatched capabilities to rapidly drive product innovation.

“This acquisition is a natural step for PTC and its customers,” said Jeff Hojlo, program director, product innovation, IDC. “AI and machine learning (ML) are widely discussed as two of the most impactful technologies of the future. For design, engineering, and R&D, the potential positive impacts of complementing the development process with AI and ML are astounding: lowering cost of quality (which is currently 20-25 percent of annual revenue at the average manufacturer), improving product success rate (which remains very low with more than 80 percent of products failing), and improving time to market and time to revenue by meeting customer needs accurately the first time.”

The Power of Generative Design

With generative design, engineers can interactively specify the functional requirements and goals of their design, including preferred materials and manufacturing processes—and even indicate key design parameters that take into consideration purchasing decisions, manufacturing capacity, supply chain status, and regional-required product variances. The system then uses AI and powerful high-performance computing techniques to present design alternatives for consideration as a starting point or as a final solution. By removing the constraints of human imagination and experience, engineers will be able to interact with the technology to create superior designs and innovative products more quickly.

Generative design is appealing to PTC’s vast customer base as they seek ways to:

    Increase engineering productivity
    Improve innovation and conceptual design exploration
    Develop higher-performance designs that are lighter weight, with improved durability
    Optimize new products for improved manufacturability, reduce material costs, and decrease manufacturing cycle times
    Create complex geometries optimized for additive manufacturing
    Deliver better products faster

The Impact of Artificial Intelligence

Integral to Frustum’s technology is a powerful AI component that learns, evolves, and, ultimately, performs key tasks, including:

    Providing valuable feedback to a designer early in the design phase
    Optimizing designs for multiple objectives simultaneously and offering a designer with multiple novel design alternatives, which enables companies to substantially reduce engineering cycles
    Modifying designs to manage multiple requirements and constraints, physics, materials availability, manufacturing processes, and design objectives
    Automating testing the outcomes of the design with other enterprise insights, including costing, supply chain, and quality data

Learn More – Upcoming Webcast and Live Stage Announcement

PTC will hold an informational webcast to explain the significance of this acquisition today, Tuesday, Nov. 20, at 11 a.m. EST.

    To view the slides, please join the webcast here: https://ptc.zoom.us/s/948384709
    To join the webcast audio only, please call in using:
    Toll Free: 800-857-5592
    Toll: 1-773-799-3757
    Participant passcode: PTC

In addition, PTC will feature this announcement on-stage at PTC Forum Europe, held in Stuttgart, Germany, on Nov. 28. To register for the online or virtual event, please visit: https://www.ptc.com/en/special-event/ptc-forum-europe.

The Transaction

The transaction closed on Monday, Nov. 19, 2018. The acquisition is not expected to add material revenue for 2019 or to be dilutive to the financial guidance PTC provided on Oct. 24, 2018.

Additional Resources

    Learn more about the Frustum acquisition
    Join the webcast
    PTC and ANSYS partner announcement

Forward-Looking Statements

This news release contains statements about future events, including business performance and the effect of the acquisition on our future financial results, the integration and development of solutions, and the expected value of the acquired technology to users. These statements are “forward-looking statements” and actual results may differ materially from those projected as a result of certain risks and uncertainties, including that the acquisition may not have the expected effect on future financial results and that the integration of the solutions may not occur when or as expected, and those risks and uncertainties described in PTC’s filings with U.S. Securities and Exchange Commission. These forward-looking statements reflect our beliefs as of the date of this release and we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

About PTC (NASDAQ: PTC)

PTC helps companies around the world reinvent the way they design, manufacture, operate, and service products in and for a smart, connected world. In 1986 we revolutionized digital 3D design, and in 1998 were first to market with Internet-based product lifecycle management. Today, our leading industrial innovation platform and field-proven solutions enable you to unlock value at the convergence of the physical and digital worlds. With PTC, manufacturers and an ecosystem of partners and developers can capitalize on the promise of the Internet of Things and augmented reality technology today and drive the future of innovation.

PTC.com @PTC Blogs

PTC, Creo, and the PTC logo are trademarks or registered trademarks of PTC Inc. in the United States and other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181120005326/en/

Contacts

PTC
Corporate Communications
Jack McAvoy
jmcavoy@ptc.com

Permalink : https://www.aetoswire.com/news/ptc-adds-artificial-intelligence-and-generative-design-capabilities-to-enhance-and-expand-its-cad-portfolio-with-acquisition-of-frustum/en

American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway

INGELHEIM, Germany & INDIANAPOLIS, Ind.-Tuesday 27 November 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empagliflozin as the preferred SGLT2 inhibitor for its proven benefit in reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. The recommendation, part of the ACC’s first Expert Consensus Decision Pathway on novel therapies for cardiovascular risk reduction in adults with type 2 diabetes, was released today and published online in the Journal of the American College of Cardiology.1 Empagliflozin is marketed by Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY).

The recommendation of empagliflozin is based on evidence from the landmark EMPA-REG OUTCOME® trial, which investigated the effects of empagliflozin compared with placebo when added to standard of care in adults with type 2 diabetes and established cardiovascular disease.2 In addition to the ACC Expert Consensus Decision Pathway, the American Diabetes Association® (ADA) and European Association for the Study of Diabetes (EASD) recently published a Consensus Report recommending SGLT2 inhibitors, such as empagliflozin, to help manage cardiovascular outcomes in patients with type 2 diabetes.3 Empagliflozin is also the only SGLT2 inhibitor recommended in the ADA 2018 Standards of Medical Care in Diabetes for reducing the risk of cardiovascular death in people with type 2 diabetes and established cardiovascular disease.4 Worldwide, more than 50 treatment guidelines have been updated to include findings from the EMPA-REG OUTCOME trial® in their endorsement of type 2 diabetes treatments with proven cardiovascular benefits.5

“People with type 2 diabetes are at increased risk of serious cardiovascular complications and events, even when their blood sugar is under control, which is why a focus on reducing cardiovascular risk in people with diabetes is critical,” said Waheed Jamal, M.D., Corporate Vice President and Head of CardioMetabolic Medicine, Boehringer Ingelheim. “The ACC Expert Consensus Decision Pathway, along with the Consensus Report from the ADA and EASD, all now recommend that comprehensive cardiovascular care for adults with type 2 diabetes and established cardiovascular disease includes a treatment shown to improve cardiovascular outcomes in this population, such as empagliflozin. These recommendations reflect a fundamental shift in the management of type 2 diabetes, moving beyond glucose control to a broader strategy of comprehensive cardiovascular risk reduction.”

The 2018 ACC Expert Consensus Decision Pathway emphasises the need for a collaborative treatment approach by healthcare providers to reduce cardiovascular risk and improve survival in people with type 2 diabetes, a growing public health epidemic.1 People with diabetes are up to four times more likely to develop cardiovascular disease than those without diabetes, and cardiovascular disease is the leading cause of death associated with diabetes.6,7

The ACC Expert Consensus Decision Pathway’s recommendation of empagliflozin, along with those of the ADA and EASD, represents a shift towards a comprehensive and team-based approach for managing the overall health of people with type 2 diabetes. The ACC encourages cardiologists to work as part of a broad healthcare provider team including primary care, internal medicine and endocrinology physicians, as well as nurse practitioners, physician assistants, diabetes educators and pharmacists, to improve the care and outcomes of people with type 2 diabetes.1

“The EMPA-REG OUTCOME trial® ushered in a new era for managing type 2 diabetes. Now, cardiovascular risk reduction is prioritised as a primary goal of diabetes management,” said Sherry Martin, M.D., Vice President, Medical Affairs, Lilly. “With the adoption of the ACC’s Expert Consensus Decision Pathway and ADA-EASD Consensus Report, the cardiology community will have an important role as part of the healthcare team managing cardiovascular risk in people with type 2 diabetes.”

About EMPA-REG OUTCOME® (NCT01131676)2
EMPA-REG OUTCOME® was a long-term, multicenter, randomised, double-blind, placebo-controlled trial of more than 7,000 patients from 42 countries with type 2 diabetes and established cardiovascular disease.

The study assessed the effect of empagliflozin (10 mg or 25 mg once daily) added to standard of care compared with placebo added to standard of care. Standard of care was comprised of glucose-lowering agents and cardiovascular drugs (including for blood pressure and cholesterol). The primary endpoint was defined as time to first occurrence of cardiovascular death, non-fatal heart attack or non-fatal stroke.

The overall safety profile of empagliflozin was consistent with that of previous trials.

About Diabetes and Cardiovascular Disease
More than 425 million people worldwide have diabetes, of which over 212 million are estimated to be undiagnosed.8 By 2045, the number of people with diabetes is expected to rise to 629 million people worldwide.8 Type 2 diabetes is the most common form of diabetes, responsible for around 90 percent of diabetes cases in high-income countries.8 Diabetes is a chronic condition that occurs when the body either does not properly produce, or use, the hormone insulin.8

Due to the complications associated with diabetes, such as high blood sugar, high blood pressure and obesity, cardiovascular disease is a major complication and the leading cause of death associated with diabetes.9,10 People with diabetes are two to four times more likely to develop cardiovascular disease than people without diabetes.10 In 2017, diabetes caused four million deaths worldwide, with cardiovascular disease as the leading cause.8 Approximately 50 percent of deaths in people with type 2 diabetes worldwide are caused by cardiovascular disease.7,11

Having a history of diabetes at age 60 can shorten a person’s life span by as much as six years compared with someone without diabetes. And having both diabetes and a history of heart attack or stroke by age 60 can shorten a person’s life span by as much as 12 years compared with someone without these conditions.12

More than 50 guidelines have been updated to endorse type 2 diabetes agents with proven cardiovascular benefits since 2016, including a recent Consensus Report initiated by the American Diabetes Association® and European Association for the Study of Diabetes, recommending that, in patients with type 2 diabetes and established atherosclerotic cardiovascular disease, SGLT2 inhibitors (such as empagliflozin) or GLP1 receptor agonists with proven cardiovascular benefits are recommended as part of glycaemic management.13,14

About Empagliflozin
Empagliflozin (marketed as Jardiance®) is an oral, once daily, highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor and the first type 2 diabetes medicine to include cardiovascular death risk reduction data in the label in several countries.15,16,17

Inhibition of SGLT2 with empagliflozin in people with type 2 diabetes and high blood sugar levels leads to excretion of excess sugar in the urine. In addition, initiation of empagliflozin increases excretion of salt from the body and reduces the fluid load of the body’s blood vessel system (i.e. intravascular volume). Empagliflozin induces changes to the sugar, salt and water metabolism in the body that may contribute to the reductions in cardiovascular death observed in the EMPA-REG OUTCOME® trial.

Please click on the following link for ‘Notes to Editors’ and ‘References’: http://www.boehringer-ingelheim.com/press-release/empa-acc-expert-consensus-decision-pathway

Contacts

Dr Petra Kienle
Product Communication Manager
Boehringer Ingelheim
Email: press@boehringer-ingelheim.com
Phone: +49 (6132) 77 143877

Greg Kueterman
Director of Communications
Lilly Diabetes and Lilly USA
Email: kueterman_gregory_andrew@lilly.com
Phone: +1 (317) 432-5195


Permalink : https://www.aetoswire.com/news/american-college-of-cardiology-recommends-empagliflozin-as-preferred-sglt2-inhibitor-for-adults-with-type-2-diabetes-and-established-cardiovascular-disease-in-new-expert-consensus-decision-pathway/en

Mobile Operators across Middle East Set for Global 5G Leadership, According to New GSMA Reports

GCC Operators Set for Commercial 5G Launches in 2019; Supportive Regulatory Environment and Availability of Spectrum Key to Driving 5G Adoption Across Region


DUBAI, United Arab Emirates-Monday 26 November 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- The Gulf Cooperation Council (GCC) Arab States1 are set to be global leaders in the deployment of 5G networks, with all six markets expected to launch 5G mobile services in the next two years, according to two new reports released today at Mobile 360 Series – MENA. The reports from GSMA Intelligence – ‘The Mobile Economy: Middle East and North Africa 20182’ and ‘5G in MENA: GCC operators set for global leadership’ – highlight that pioneering mobile operators in the GCC Arab States are expected to launch 5G networks commercially from 2019, driving innovative new services across the region and spurring future growth. By 2025, 5G will account for 16 per cent of total connections in these markets.

“Backed by proactive government support, mobile operators, particularly in the GCC Arab States, have been quick to establish the foundations for global leadership in the deployment of 5G technology, moving rapidly from trials to early commercialization,” said John Giusti, Chief Regulatory Officer, GSMA. “While we are encouraged by their progress to date, it is imperative that the region’s governments create a regulatory environment that allows 5G to flourish, including releasing sufficient spectrum, so that businesses and citizens can fully enjoy the innovative new services that 5G will deliver, as well as the resulting socio-economic benefits.”

Policy Central to Realising 5G Digital Future

The reports encourage policymakers to establish spectrum roadmaps that commit to releasing sufficient quantities of spectrum across all frequency ranges to enable operators to meet coverage and capacity. They further note that governments should implement taxation policies that could improve affordability and boost digital inclusion, and adopt an approach to licence renewals that enables operators to make long-term investment decisions rather than maximising government revenue.

A Region of Rapid Subscriber Growth, Increased Smartphone Adoption

There are currently 381 million unique mobile subscribers (Q2 2018) across the MENA region, accounting for 64 per cent of the population.3 However, it is a diverse region in terms of market maturity, encompassing the advanced GCC Arab States, where 77 per cent of the population on average are mobile subscribers, alongside other North African countries such as Comoros, Djibouti and Somalia, where subscriber penetration is below 30 per cent.4 Between 2017 and 2025, the MENA region as a whole will see the fastest subscriber growth rate of any region except Sub-Saharan Africa, growing to reach 459 million or 69 per cent of the population.

The number of smartphone connections across MENA stands at 332 million as of Q2 2018, accounting for just over 50 per cent of total connections in the region. This is expected to continue growing at an average annual rate of 8 per cent to reach 587 million smartphone connections by 2025, or just under three-quarters of total connections across the MENA region. The UAE remains a global leader in terms of smartphone adoption, second only to Singapore, with smartphones accounting for 85 per cent of total connections. High mobile broadband usage and smartphone adoption has also resulted in more people across the region using data services such as IP messaging and using their mobile phones to watch online video.

Immersive Digital Entertainment Presents Revenue Opportunities in the Early 5G Era

The reports highlight how operators will offer enhanced mobile broadband services in early 5G deployments, while applications and services for enterprises will be introduced later. There will be significant opportunities for operators across new consumer-oriented services such as immersive reality, eSports and enhanced in-venue digital entertainment at stadiums and music venues, for example. Further, video consumption on mobile devices will evolve to include newer augmented reality and virtual reality applications that will make content even more immersive and data intensive.

Mobile Contributing to Jobs and Economic Growth

In 2017, the mobile industry contributed approximately $165 billion to the MENA region’s economy, equivalent to 4 per cent of GDP. This contribution is expected to increase to over $200 billion by 2022 as countries in the region benefit from improvements in productivity and efficiency brought about by increased take-up of mobile services. The mobile ecosystem also supported more than 1 million jobs in 2017, which includes workers directly employed in the ecosystem and jobs indirectly supported by the economic activity generated by the sector. Further, the mobile industry made a substantial contribution to the funding of the public sector, with more than $17 billion raised in 2017 in the form of general taxation.

To access the ‘The Mobile Economy: Middle East and North Africa 2018’ report and related infographics please visit here: https://www.gsma.com/mobileeconomy/mena/. To access the ‘5G in MENA: GCC operators set for global leadership’ report, please go here: https://www.gsmaintelligence.com/research/?file=41a57dc7d3baad611133be7deb481930&download.

Notes to Editors

1. GCC Arab States: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and UAE

2. The MENA region includes 25 countries (source: GSMA Intelligence): Algeria, Bahrain, Comoros, Djibouti, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, Turkey, United Arab Emirates and Yemen. North Africa includes: Algeria, Egypt, Libya, Mauritania, Morocco and Tunisia.

3. Unique mobile subscribers can account for multiple connections. Total mobile connections (active SIM cards, excluding licensed cellular IoT) in MENA stood at 634 million in 2017, forecast to rise to 791 million by 2025.

4. Other Arab States: Comoros, Djibouti, Iraq, Jordan, Lebanon, Palestine, Somalia, Sudan, Syria and Yemen

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contacts

Asad Abbasi
+971 52 861 4230
AAbbasi@webershandwick.com

GSMA Press Office
mobile360pressoffice@gsma.com


Permalink : https://www.aetoswire.com/news/mobile-operators-across-middle-east-set-for-global-5g-leadership-according-to-new-gsma-reports/en

Frost & Sullivan Co-Organise With AMIP to Host Healthcare Meeting to Discuss Growth Opportunities and Challenges in the Pharmaceutical Industry and Digital Health Tech Readiness in Morocco

 Senior industry experts will come together to discuss game changing trends in the pharmaceutical industry and the implications for Morocco

DUBAI, United Arab Emirates-Monday 26 November 2018 [ AETOS Wire ]

Frost & Sullivan has co-organised with AMIP (Moroccan Pharmaceutical Industry Association) to host its very first Healthcare Meeting on December 4, 2018 at the Hyatt Regency Hotel, Casablanca, Morocco.

2018 will be a tipping point for mainstream adoption of popular digital health tech/solutions and the transition of noble technologies from research/proof-of-concept to actionable healthcare and clinical applications. Envisaging huge growth opportunities, Frost & Sullivan will host the meeting and discuss the global trends and the growth opportunities in the healthcare and life sciences sector.

At the start of every year, Frost & Sullivan’s Transformational Health team brainstorms top predictions in the healthcare space. Despite on-going political uncertainties and rising cost pressures, the global healthcare industry will register a stable growth rate in 2018 and will cross the $1.85 trillion mark in terms of manufacturer revenues. Digital health investments crossed $6.5 billion in 2017, up to 109% from the previous year. This growth curve is expected to continue in 2018 as technologies and platform solutions that promote innovation around care quality, outcomes, and chronic disease management will continue to rise. High growth opportunities in emerging markets will change the paradigms of product development and geographic rollouts.

The Frost & Sullivan Healthcare and Life Sciences experts are predicting big disruptions, transformations and innovations in the coming years as the healthcare industry continues to overhaul outmoded business models.

“Our interactive workshop is designed to help managers and CEOs understand key issues affecting the healthcare industry globally,” noted Sandeep Sinha, Vice President & Head, Healthcare and Life Sciences, Frost & Sullivan. “Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as artificial intelligence and blockchain will help shape the healthcare industry into a much-anticipated, value-based care paradigm.”

Attend the Frost & Sullivan Healthcare meeting to get updated on the most recent trends and future opportunities in the Healthcare domain, exchange your ideas with industry peers, engage in discussions with Frost & Sullivan healthcare experts, and more. If you are interested in attending the event, click here to register.

If you are interested in gaining more information on this meeting and speaking with our experts, please get in touch with Mourad Oubrich at mourad.oubrich@frost.com

About Frost & Sullivan:

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion

Contacts

Anita Chandhoke, Corporate Communications - MEA
E: achandhoke@frost.com

http://ww2.frost.com

Twitter: @Frost_Sullivan & @Frost_MENASA
Facebook: http://www.facebook.com/frostandsullivan
LinkedIn: https://www.linkedin.com/showcase/frost-&-sullivan-%E2%80%93-middle-east-north-africa-south-asia/

Permalink : https://www.aetoswire.com/news/frost-amp-sullivan-co-organise-with-amip-to-host-healthcare-meeting-to-discuss-growth-opportunities-and-challenges-in-the-pharmaceutical-industry-and-digital-health-tech-readiness-in-morocco/en

Bio Farma : Sharing experience in acquiring WHO Pre-qualification to OIC Member Countries

JAKARTA, Indonesia-Monday 26 November 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- M. Rahman Roestan, President Director of Bio Farma, has been invited to speak on Bio Farma’s experience in acquiring WHO pre-qualification for Vaccines, at The First Meeting of Heads of National Medicines Regulatory Authorities (NMRAs) held by National Agency of Drug and Food Monitoring (BPOM) of Indonesia.

Rahman said,“currently Bio Farma has more than 12 vaccine products WHO pre-qualified. In order for a vaccine manufacturer to have its vaccines WHO pre-qualified, it is mandatory for the National Regulatory Agency (NRA) of the country to be accredited by WHO. This verifies that the NRA is functional, meeting all the indicators outlined by WHO. I take pride that our National Agency for Drug and Food Monitoring (BPOM) is WHO accredited”.

Penny Lukito, Head of BPOM added, "There are only seven OIC members states having the ability to manufacture vaccine". Penny stated that Indonesia is very fortunate to have Bio Farma a state-owned enterprise and the sole vaccine and antisera manufacturer for human use. The company has not only supported the National Immunization Program through the supply of vaccines, but exported its products to more than 140 countries as well, of which 49 are OIC member countries.

Rahman added, “Numerous OIC member countries such as Morocco, Tunisia, Turkey have procured vaccines from Bio Farma, including Saudi Arabia. Apart from exporting our vaccines, we are also open to discuss technology transfer for down stream production of vaccines to support OIC member countries in attaining self-reliance on vaccines. Joint research could another option for collaboration”.

The meeting will be held in response to the strong urge among OIC Countries to be self-sufficient and ultimately self-reliant in drugs including vaccines, through, among others, strengthening of the countries’ National Regulatory Authorities.

Bio Farma is a state-owned producer of Vaccines and Antisera, currently developing into a Lifescience company. More than 140 countries have used Bio Farma Vaccine products, especially developing countries, and 49 of them are countries that are members of the Organization of Islamic Cooperation. Bio Farma is the largest vaccine manufacturer in South East Asia.

For further information refer to website www.biofarma.co.id

Contacts

Media:
N. Nurlaela Arief
Head of Corporate Communications Dept.
Bio Farma
Email : lala@biofarma.co.id
Phone : + 62 22 2033755 Fax : +62 22 2041306
www.biofarma.co.id
or
Contact Center
HALO BPOM : 1-500-533
Text only : 081-219-999-533
Email : halobpom@pom.go.id
Twitter : @BPOM_RI



Permalink : https://www.aetoswire.com/news/bio-farma-sharing-experience-in-acquiring-who-pre-qualification-to-oic-member-countries/en